D0X
Atlas Energy Corp., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. The company was formerly known as Willow Biosciences … Read more
D0X (D0X) - Total Liabilities
Latest total liabilities as of September 2025: €164.00K EUR
Based on the latest financial reports, D0X (D0X) has total liabilities worth €164.00K EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
D0X - Total Liabilities Trend (2021–2024)
This chart illustrates how D0X's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
D0X Competitors by Total Liabilities
The table below lists competitors of D0X ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Handok
KO:002390
|
Korea | ₩536.54 Billion |
|
Los Andes Copper Ltd
OTCQX:LSANF
|
USA | $24.03 Million |
|
Yangarra Resources Ltd
PINK:YGRAF
|
USA | $290.53 Million |
|
Taokaenoi Food & Marketing Public Company Limited
BK:TKN
|
Thailand | ฿1.92 Billion |
|
Amicogen Inc
KQ:092040
|
Korea | ₩139.22 Billion |
|
Birlesim Muhendislik Isitma Sogutma Havalandirma Sanayi & Ticaret Sirketi AS
IS:BRLSM
|
Turkey | TL3.74 Billion |
|
Auburn National Bancorporation Inc
NASDAQ:AUBN
|
USA | $-89.61 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down D0X's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 171.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how D0X's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for D0X (2021–2024)
The table below shows the annual total liabilities of D0X from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.99 Million | -7.51% |
| 2023-12-31 | €3.24 Million | +82.47% |
| 2022-12-31 | €1.77 Million | -66.74% |
| 2021-12-31 | €5.33 Million | -- |